We have investigated glucose transport proteins in isolated human adipocytes. Using the cytochalasin B binding assay to measure glucose transporters in subcellular membrane subfractions, we found that insulin induced translocation of intracellular glucose transporters to the cell surface. Isoelectric focusing of glucose transporters photolabeled with [H]cytochalasin B revealed two distinct glucose transporter isoforms in low density microsomes focusing at pH 5.6 and pH 6.4, but only the pH 5.6 isoform was detectable in plasma membranes and only the pH 6.4 form was found in the high density microsomes. Insulin recruited only the pH 5.6 glucose transporter from the low density microsomes to the plasma membrane with no effect on the pH 6.4 transporter isoform. The results suggest that the pH 6.4 species is an immature form of the glucose transporter initially located in the high-density microsome fraction, which then migrates to the low-density microsomes where it matures (converted to pH 5.6 species) and becomes available for insulin-mediated recruitment to the plasma membrane.
Introduction
There is a considerable body ofevidence that postreceptor defects play an important role in the pathogenesis of the insulin resistance in non-insulin-dependent diabetes mellitus (NIDDM)' and obesity (1) (2) (3) . Further, studies in adipocytes isolated from these patients show that impaired insulin responsiveness is largely due to defects in the glucose transport system (4, 5) . However, the cellular and molecular events that accompany these processes are still unknown. Major impediments in this area of research have been the lack of information on the molecular properties and subcellular distribution of the human adipocyte glucose transporter, and how it is influenced by insulin. Recently, Armoni et al. reported data on glucose transporter distribution in human omental adipocytes from normal and obese patients (6) . Although these authors provided evidence in support of the no-1. Abbreviations used in this paper: HDM, high density microsomes; LDM, low density microsomes; NIDDM, non-insulin-dependent diabetes mellitus; PAGE, polyacrylamide gel electrophoresis; PM, plasma membranes.
tion that insulin stimulates glucose transport in the human adipocyte via a mechanism similar to that in rat adipocytes; translocation of glucose transporters from an intracellular pool to the plasma membrane (7, 8) , biochemical events that accompany these processes are still unknown.
We have recently shown that there is heterogeneity ofglucose transporter species in the intracellular pool in rat adipocytes and that only one glucose transporter isoform is translocatable by insulin (10) . Our current goal was to study in human adipocytes the mechanism by which insulin activates glucose transport at the biochemical level. This is important since characterization ofthe human adipocyte glucose transport system is a prerequisite to elucidate potential structural and functional defects of the glucose transporter molecule and/or the translocation process in pathophysiologic states (1) (2) (3) (4) (5) 9) . The studies presented here revealed that the biochemical events that accompany insulin activation of glucose transport in human omental adipocytes are similar to those in rat adipocytes and provide further information on the subcellular distribution, and structure of the glucose transporter isoforms.
Methods
Materials.
[3H]cytochalasin B (10) (11) (12) (13) (14) (15) Ci/mmol sp act) and endoglycosidase F were obtained from New England Nuclear, Boston, MA (5) . Subcellular fractions from isolated adipocytes were prepared by differential ultracentrifugation as described by Karnieli et al. (12) . Membrane proteins were suspended to a final concentration of 1-5 mg/ml and stored at -80°C. Protein was determined by the method of Lowry et al. (13) as modified by Peterson (14) . Marker and cytochalasin E (2 ,uM), the membranes were irradiated for 5 min at 4°C using a high-intensity ultraviolet-lamp (253 nM). Experiments involving D-or L-glucose were carried out as described above except that the sugar (500 mM) was incubated with the membranes for 30 min before the addition of cytochalasin B.
Membranes covalently crosslinked to [3H]cytochalasin B were solubilized by boiling for 5 min in Laemmli sample buffer (16), followed by centrifugation and analysis by SDS-PAGE as previously described (10) . Proteins corresponding to a molecular mass of 40-55 kD were excised from the slab gels and electrophoretically extracted as described by Hunkapiller et al. (17) .
Isoelectricfocusing. The extracted and concentrated SDS-solubilized glucose transporter was subjected to isoelectric focusing on cylindrical polyacrylamide gels. Gel composition and isoelectric focusing conditions were as described previously (18) . Duplicate gels were run; one was processed for scintillation counting as above, while slices from the other gel were extracted for 1 h in I ml of water (four slices per tube) and the pH determined (16) .
Immunological identification ofthe glucose transporter. Aliquots of the membrane subfractions isolated from human omental adipocytes were taken up in a Laemmli sample buffer and analyzed by SDS-PAGE on 1.5-mm slab gels containing 9% polyacrylamide resolving gel. The gels were run at 40 mA for 2.5 h. The proteins were transferred to nitrocellulose paper as described by Towbin et al. (19) , and reacted with an antiserum against the purified human erythrocyte glucose transporter.
Crossreacting protein was visualized using '251-protein A according to the method of Wheeler et al. (20) . Autoradiography was carried out at -80°C using Kodak XARS film and a lighting-plus intensifying screen (Cronex, E. I. Dupont de Nemours, Inc., Wilmington, DE).
Endoglycosidase F treatment ofmembranes.
[3H]Cytochalasin B labeled low density microsomes (300 Mg) were incubated with I U of endoglycosidase F (New England Nuclear) in 0.1 ml of 50 mM phosphate buffer, pH 6.1, containing 1% SDS, 1% Triton X-100, and 1% mercaptoethanol for 16 h at 37°C. The protease inhibitors pepstatin (5 ,ug/ml), leupeptin (5 Mg/ml) and aprotinin (5 Mg/ml) were present.
After the incubation, samples were prepared for two-dimensional electrophoresis or immunoblotting as described above. (15) . As shown in Fig. 1 , insulin caused the translocation ofglucose transporters from the LDMs to the PMs in human omental adipocytes, which is consistent with the findings in rat adipocytes (7, 8, 24) and other insulin sensitive tissues, e.g., rat diaphragm (25) . Fig. 2 fractions from isolated human omental and subcutaneous adipocytes were prepared and the purity of the fractions was determined by measuring the activity of specific marker enzymes in each fraction. Table I shows the specific activities of various marker enzymes characteristic of different subcellular organelles.
Adenylate cyclase was used as the marker enzyme (21) ofplasma membranes (PMs) and its specific activity was increased 16-fold over the homogenate. In addition, there was no appreciable contamination ofthis plasma membrane marker in either high density microsomes (HDMs) or low density microsomes (LDMs). The activity of cytochrome c reductase, a marker enzyme of HDMs (22) , was increased 49-fold in HDMs over the homogenate with minor activity in PMs and LDMs. UDP-Galactose N-acetylglucosamine galactosyltransferase, a marker enzyme that identifies the Golgi apparatus (23) PMs: 20 Mg) were subjected to SDS-PAGE (9% resolving gels), blotted to nitrocellulose, and glucose transporters were detected using an antiserum raised against the purified erythrocyte glucose transporter (26) . The results show that the human omental adipocyte transporter has an apparent molecular mass of46 kD on SDS-PAGE in all membrane species. In addition, insulin caused a decrease of carrier proteins in LDMs together with a concomitant increase in PMs. Therefore, insulin appeared to stimulate a translocation ofglucose transporters from an intracellular pool to the plasma membrane, in confirmation of the findings from the cytochalasin B binding studies ( Figs. 1 and 2 ). It should be noted that the relative intensity ofthe PM glucose transporter in Fig. 3 is less due to the smaller amount of protein (20 Cells were incubated with and BLDM ILDM BPM IPM without insulin and subcellular membrane fractions-basal low-density microsomes (BLDM), insulin low-density microsomes (ILDM), basal plasma membrane (BPM) and insulin plasma membrane (IPM)-were prepared as described in Methods. Membranes were analyzed by SDS-PAGE on 9% resolving gels, and transferred to nitrocellulose. The nitrocellulose blots were then incubated with antiserum raised against purified human erythrocyte glucose transporter, and the crossreacting proteins identified using 125I-protein A and autoradiography. Only the 35-68 kD region of the autoradiogram is shown for clarity. 100 Mg of BLDM, ILDM and 20 ,g of plasma membranes (BPM, IPM) were used. tocol (10) involved SDS-PAGE. Fig. 4 Following SDS-PAGE, membrane proteins of molecular mass of 40-55 kD were excised from duplicate gels and electrophoretically eluted as described by Hunkapiller (17) . As shown in Fig. 5 Gel Slice Number sional electrophoresis. As shown in Fig. 7 A and The different charge properties of LDM glucose transporters could correspond to covalent modification of the glucose transporter such as differences in glycosylation. To assess this possibility we incubated photolabeled basal-and insulin LDMs with and without endoglycosidase F as described in Methods. Analysis of the membrane proteins by SDS-PAGE followed by immunological detection and autoradiography is seen in Fig. 8 . Endoglycosidase F treatment resulted in a higher mobility of about half (46%) of the original 46 kD-protein, now having a molecular mass of 38 kD, while the other half (54%) still showed the original mass of 46 kD.
To determine the effects of endoglycosidase F on glucose transporter isoforms, these proteins were then resolved by isoelectric focusing. As shown in Fig. 9 , treatment of [3H]cytochalasin B photolabeled basal (A) and insulin (B) LDMs with endoglycosidase F generated a new glucose transporter isoform focusing at pH 6.1. The pH 5.6 transporter isoform was now almost entirely absent while the pH 6.4 glucose transporter isoform was not sensitive to endoglycosidase F treatment. Thus, endoglycosidase F induced an alkaline shift ofthe pH 5.6 glucose transporter isoform consistent with the removal of charged Nlinked sugar residues from the carrier. Therefore, the charge heterogeneity observed in the two isoforms is at least partially due to differences in glycosylation. Endoglycosidase F treatment of the membranes had no effect on the D-glucose-inhibitable [3Hlcytochalasin B-labeled protein profile; for reasons of clarity these data are not shown in Fig. 9 .
Discussion
The purpose of this study was to gain insight into the molecular mechanism of insulin action on glucose transport in human adipocytes. Using a modified two-dimensional electrophoresis approach (10) we have demonstrated both the biochemical and functional heterogeneity of glucose transporters in human omental adipocytes. In subcellular membrane fractions, there was charge heterogeneity of glucose transporter species in LDMs since we observed two isoforms focusing at pH 6.4 and pH 5.6. In contrast, only the pH 5.6 species was present in the PMs and only the pH 6.4 species was detected in the HDMs. We consider it extremely unlikely that glucose transporter isoforms could 706 Matthaei, Garvey, Horuk, Hueckstaedt, and Olefsky Gel Slice Number have been generated by partial proteolysis ofthe molecule, since protease inhibitors (aprotinin, pepstatin, and leupeptin) were present during the entire procedure. Furthermore, partial proteolysis would have been expected to generate multiple forms of transporters in the HDM and PM fractions, where only one glucose transporter isoform was observed. The finding that insulin induced the translocation ofonly the pH 5.6 glucose transporter isoform from the LDMs to the PMs in human adipocytes is of particular significance and is consistent with our recently reported results from rat adipocytes (10). Insulin did not cause redistribution of the pH 6.4 glucose transporter isoform. Obviously, the pH 5.6 species is the biologically active form of the transporter as far as uptake ofglucose into the cell is concerned. Whether the pH 6.4 isoform is capable oftransporting I-glucose remains to be determined.
The existence of glucose transporter heterogeneity in the LDMs is at least partially due to differences in glycosylation, since endoglycosidase F shifted the pH 5.6 isoform to a more alkaline isoelectric point, now focusing at pH 6.1, while the pH 6.4 glucose transporter isoform was not sensitive to endoglycosidase F treatment. This endoglycosidase F-induced alkaline shift of the pH 5.6 glucose transporter indicates cleavage of charged asparagine-linked core oligosaccharides which also altered the mobility of transporters on SDS-PAGE. Using Taken together with the observation that endoglycosidase F treatment results in an alkaline shift ofthe pH 5.6 glucose transporter isoform to pH 6.1, one could speculate that the endoglycosidase F-generated 38-kD protein is the deglycosylated pH 5.6 glucose transporter isoform, now having an isoelectric point of pH 6.1. The pH 6.4 glucose transporter isoform may represent an immature glucose transporter species that is not endoglycosidase F sensitive. It is not clear whether the endoglycosidase F insensitivity is due to inaccessibility of N-linked core oligosaccharides to the enzyme or due to other structural features ofthis isoform. It should be noted that the pH 6.4 isoform in untreated membranes cannot be simply a naturally occurring deglycosylated form of the transporter because its SDS-PAGE mobility was 46 kD, not 38 kD. Similarly, after endoglycosidase F treatment of LDMs, the residual 46 kD species is unlikely to be enzyme resistant simply due to lack of oligosaccharide side chains, since its mobility is not in the 38-41-kD range reported for the deglycosylated form of the glucose transporter (29, 30) . In this regard, Haspel et al. (29, 30) 
